Primary Job Title Chief Executive Officer Primary Organization PhaseBio Pharmaceuticals
Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Jonathan has more than 20 years experience in business development, marketing and commercial operations.
Prior to PhaseBio he served as Vice President, Business Development for Amylin Pharmaceuticals from 2007 until its sale to Bristol-Myers Squibb in 2012. Mr. Mow was Co-founder, Vice President, Commercial and Business Development, and
Secretary of Corus Pharma, Inc. until their acquisition by Gilead Sciences in 2006.
He also led the Business Development efforts for PathoGenesis Corporation, culminating with the company’s acquisition by Chiron Corporation in 2000.
Prior to those roles, he held positions in marketing at Bristol Myers-Squibb, Wyeth/Lederle International and sales and marketing research at Syntex Laboratories.
